Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06991205 · ClinicalTrials.gov registry record · NA

Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain

A NA study of Orthopedic Disorder and Upper Extremity Pain, sponsored by Jafar Bakhshaie.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06991205: Recruiting NA study of Orthopedic Disorder and Upper Extremity Pain, sponsored by Jafar Bakhshaie.

NCT06991205 is a NA study of Orthopedic Disorder and Upper Extremity Pain that is actively recruiting participants, run by Jafar Bakhshaie. The registered enrollment target is 50 participants, below the 130-participant average among 10 other Orthopedic Disorder trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06991205, a NA study of Orthopedic Disorder and Upper Extremity Pain, is actively recruiting participants, sponsored by Jafar Bakhshaie.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The investigator aims to conduct a feasibility randomized controlled trial (RCT) (N=50) to test the feasibility, acceptability, and credibility of an asynchronous web-based mind-body intervention (Toolkit for Resilient Life beyond Pain and Substance Use; Web-TIRELESS) versus web-based minimally enhanced usual care (Web-MEUC) among adult patients with a painful non-traumatic upper-extremity condition(s) (PNUC) and commorbid risky substance use. Deliverables: \[1\] Adapt and refine open pilot protocol, patient recruitment, and other study materials. \[2\] Assess the feasibility, acceptability, and credibility of Web-TIRELESS and Web-MEUC in preparation for future research.

Primary Outcome

Assesses the degree to which one believes the intervention will effectively manage their condition, substance use, and related worry. Possible scores range from 3 to 27 for both the credibility and the expectancy subscales. Higher scores represent higher credibility and expectancy.

Interventions

  • BEHAVIORAL Web-TIRELESS
  • OTHER Web-MEUC

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-09-15
Est. Completion 2027-03-01
Phase NA
Jafar Bakhshaie

2 total trials

What NCT06991205 shows while recruiting

NCT06991205 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 130-participant average among 10 other Orthopedic Disorder trials with a reported enrollment target (62% lower).

The record links to 4 conditions, with Orthopedic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Web-TIRELESS is the first listed.

NCT06991205 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06991205 about?

NCT06991205 is a clinical study titled "Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain". The investigator aims to conduct a feasibility randomized controlled trial (RCT) (N=50) to test the feasibility, acceptability, and credibility of an asynchronous web-based mind-body intervention (Toolkit for Resilient Life beyond Pain and Substance Use; Web-TIRELESS) versus web-based minimally enha...

What is the current status of trial NCT06991205?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-15. Estimated completion is 2027-03-01.

What conditions does trial NCT06991205 study?

This clinical trial studies the following conditions: Orthopedic Disorder, Upper Extremity Pain, Nontraumatic Injury, Risky Substance Use.

What interventions are being tested in trial NCT06991205?

The interventions under investigation include: Web-TIRELESS (BEHAVIORAL), Web-MEUC (OTHER).

Who is sponsoring clinical trial NCT06991205?

This trial is sponsored by Jafar Bakhshaie, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06991205 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Orthopedic Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06991205's enrollment target sits among peer trials

50 8th of 10 higher than 3 of 10 other Orthopedic Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Orthopedic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06991205, the US trial registry maintained by the National Library of Medicine. NCT06991205 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.